Millennium Dental Technologies U.S. Navy Contract Milestone Completed

CERRITOS, Calif., March 27, 2017 /PRNewswire/ — Millennium Dental Technologies, Inc. (MDT) announces another milestone in a multi-million dollar, multi-year contract with the United States Navy making the LANAP® Protocol available to treat US Navy service men and women with gum disease. Seven PerioLase® MVP-7™ lasers were deployed as part of Millennium’s Periolase Periodontal Package for the LANAP® Protocol to naval bases worldwide to treat periodontitis and peri-implantitis.

“This important milestone denotes the continued dedication of Millennium to our nation’s armed forces, as well as both the Army’s and Navy’s efforts to provide the best gum disease treatment possible to our soldiers and sailors, and return them to their service duties faster than conventional periodontitis treatment regimens,” states Robert H. Gregg, DDS, President and Chairman of the Board for MDT.

The LANAP® protocol is the only laser gum disease treatment to have rigorous, peer-reviewed, published scientific evidence, along with the first and only FDA clearance for True Periodontal Regeneration™.  True periodontal regeneration is the gold standard of healing for lost tissues due to destructive periodontal disease.  True periodontal regeneration results in the functional regeneration of new alveolar bone, periodontal ligaments, and cementum destroyed by gum disease.

ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.: Headquartered in Cerritos, Calif., Millennium Dental Technologies, Inc., is the developer of the LANAP® Protocol for the treatment of gum disease and the manufacturer of the PerioLase MVP-7 digital dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT’s FDA-cleared LANAP® Protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional surgery. The Nd:YAG PerioLase MVP-7 has the power and versatility to perform a wide range of soft- and hard-tissue laser procedures, including the LAPIP™ protocol for the treatment of ailing dental implants. The company’s founding clinician, Robert H. Gregg, II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients—and to remain true to the guiding principle—”It’s all about the patient.”